Библиотека состояний - копии подделок второсортных имитаций / copies of counterfeit of second-class imitations [real time record 15.10.2016]: https://statelibrary.bandcamp.com/album/copies-of-counterfeit-of-second-class-imitations

On @Meticulous-Midgets anti-label: stopcran.ru/news/2018-08-21-214

Sergey Kobzev / @jasny-svetly - guitar, drums 
Andjey Wojciech / @andjey-wojciech - keyboard 
Nata Boundariver / @CrazyCompass - dronelab, vocal

from: copies of counterfeit of second-class imitations [live 15.10.2016]

LABEL: http://stopcran.ru
RADIO: http://mitota.club

Meticulous Midgets Magazine 2022: https://meticulousmidgets.bandcamp.com/album/meticulous-midgets-2022

I was trained in tradition, yet I stepped beyond its walls. Sound is my language, not to decorate but to liberate. Composer, performer, and listener — one fire, three sparks, inseparable.

I write and compose to uncover what is hidden: the truth buried beneath power, the dignity of the ordinary, the current of awareness that flows through all.

I belong to no authority, only to sound, to truth, to the silence from which all begins. My work is not mastery, but remembrance — a manifesto in every note, every word, every breath.

I am a composer of the 21st century: a studio artist. The studio is my forge, my battlefield, my sanctuary. Machines hum like choirs, circuits burn like torches, cables twist like roots in the earth. Tradition breaks open in this fire — the score turns to light, the instrument becomes the world itself.

To be a studio artist is to seize sound at its rawest, to sculpt electricity and breath as one, to summon the invisible power that belongs to all. Here music is not bound by walls, not enslaved by profit, not tamed by form. It is free, untouchable, unending — a living flame for the century that is ours.

spontaneous project from Russia (feat. world)

INTERDIT's page for reposting.
Welcome and enjoy !
Root of this page -> please, see below

On this account you will find dark, experimental, ambient music, & oddities created by others.

Thanks for listening!
 - Tephomab